Discovery of a Pyrimidinedione Derivative with Potent Inhibitory Activity against Mycobacterium tuberculosis Ketol-Acid Reductoisomerase

被引:10
作者
Lin, Xin [1 ]
Kurz, Julia L. [1 ]
Patel, Khushboo M. [1 ]
Wun, Shun Jie [1 ]
Hussein, Waleed M. [1 ,2 ]
Lonhienne, Thierry [1 ]
West, Nicholas P. [1 ]
McGeary, Ross P. [1 ]
Schenk, Gerhard [1 ]
Guddat, Luke W. [1 ]
机构
[1] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia
[2] Helwan Univ, Fac Pharm, Pharmaceut Organ Chem Dept, Helwan, Egypt
关键词
crystal growth; drug design; ketol-acid reductoisomerase; library screening; tuberculosis; NATIONAL-CANCER-INSTITUTE; CRYSTAL-STRUCTURE; BIOLOGICAL EVALUATION; DRUG DISCOVERY; NADPH BINDING; INDUCED FIT; ISOMEROREDUCTASE; SPECIFICITY; RESOLUTION; INTEGRASE;
D O I
10.1002/chem.202004665
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
New drugs aimed at novel targets are urgently needed to combat the increasing rate of drug-resistant tuberculosis (TB). Herein, the National Cancer Institute Developmental Therapeutic Program (NCI-DTP) chemical library was screened against a promising new target, ketol-acid reductoisomerase (KARI), the second enzyme in the branched-chain amino acid (BCAA) biosynthesis pathway. From this library, 6-hydroxy-2-methylthiazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione (NSC116565) was identified as a potent time-dependent inhibitor of Mycobacterium tuberculosis (Mt) KARI with a K-i of 95.4 nm. Isothermal titration calorimetry studies showed that this inhibitor bound to MtKARI in the presence and absence of the cofactor, nicotinamide adenine dinucleotide phosphate (NADPH), which was confirmed by crystal structures of the compound in complex with closely related Staphylococcus aureus KARI. It is also shown that NSC116565 inhibits the growth of H37Ra and H37Rv strains of Mt with MIC50 values of 2.93 and 6.06 mu m, respectively. These results further validate KARI as a TB drug target and show that NSC116565 is a promising lead for anti-TB drug development.
引用
收藏
页码:3130 / 3141
页数:12
相关论文
共 47 条
  • [1] PHENIX:: building new software for automated crystallographic structure determination
    Adams, PD
    Grosse-Kunstleve, RW
    Hung, LW
    Ioerger, TR
    McCoy, AJ
    Moriarty, NW
    Read, RJ
    Sacchettini, JC
    Sauter, NK
    Terwilliger, TC
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 : 1948 - 1954
  • [2] MX2: a high-flux undulator microfocus beamline serving both the chemical and macromolecular crystallography communities at the Australian Synchrotron
    Aragao, David
    Aishima, Jun
    Cherukuvada, Hima
    Clarken, Robert
    Clift, Mark
    Cowieson, Nathan Philip
    Ericsson, Daniel Jesper
    Gee, Christine L.
    Macedo, Sofia
    Mudie, Nathan
    Panjikar, Santosh
    Price, Jason Roy
    Riboldi-Tunnicliffe, Alan
    Rostan, Robert
    Williamson, Rachel
    Caradoc-Davies, Thomas Tudor
    [J]. JOURNAL OF SYNCHROTRON RADIATION, 2018, 25 : 885 - 891
  • [3] OXALYL HYDROXAMATES AS REACTION-INTERMEDIATE ANALOGS FOR KETOL-ACID REDUCTOISOMERASE
    AULABAUGH, A
    SCHLOSS, JV
    [J]. BIOCHEMISTRY, 1990, 29 (11) : 2824 - 2830
  • [4] Discovery, Synthesis and Evaluation of a Ketol-Acid Reductoisomerase Inhibitor
    Bayaraa, Tenuun
    Kurz, Julia L.
    Patel, Khushboo M.
    Hussein, Waleed M.
    Bilyj, Jessica K.
    West, Nicholas P.
    Schenk, Gerhard
    McGeary, Ross P.
    Guddat, Luke W.
    [J]. CHEMISTRY-A EUROPEAN JOURNAL, 2020, 26 (41) : 8958 - 8968
  • [5] Magnesium Chelating 2-Hydroxyisoquinoline-1,3(2H,4H)-diones, as Inhibitors of HIV-1 Integrase and/or the HIV-1 Reverse Transcriptase Ribonuclease H Domain: Discovery of a Novel Selective Inhibitor of the Ribonuclease H Function
    Billamboz, Muriel
    Bailly, Fabrice
    Lion, Cedric
    Touati, Nadia
    Vezin, Herve
    Calmels, Christina
    Andreola, Marie-Line
    Christ, Frauke
    Debyser, Zeger
    Cotelle, Philippe
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (06) : 1812 - 1824
  • [6] Design, Synthesis, and Biological Evaluation of a Series of 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as Dual Inhibitors of Human Immunodeficiency Virus Type 1 Integrase and the Reverse Transcriptase RNase H Domain
    Billamboz, Muriel
    Bailly, Fabrice
    Barreca, Maria Letizia
    De Luca, Laura
    Mouscadet, Jean-Francois
    Calmels, Christina
    Andreola, Marie-Line
    Witvrouw, Myriam
    Christ, Frauke
    Debyser, Zeger
    Cotelle, Philippe
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (24) : 7717 - 7730
  • [7] The crystal structure of plant acetohydroxy acid isomeroreductase complexed with NADPH, two magnesium ions and a herbicidal transition state analog determined at 1.65 angstrom resolution
    Biou, V
    Dumas, R
    CohenAddad, C
    Douce, R
    Job, D
    PebayPeyroula, E
    [J]. EMBO JOURNAL, 1997, 16 (12) : 3405 - 3415
  • [8] THE ENVELOPE OF MYCOBACTERIA
    BRENNAN, PJ
    NIKAIDO, H
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1995, 64 : 29 - 63
  • [9] General approach to reversing ketol-acid reductoisomerase cofactor dependence from NADPH to NADH
    Brinkmann-Chen, Sabine
    Flock, Tilman
    Cahn, Jackson K. B.
    Snow, Christopher D.
    Brustad, Eric M.
    McIntosh, John A.
    Meinhold, Peter
    Zhang, Liang
    Arnold, Frances H.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (27) : 10946 - 10951
  • [10] Cofactor specificity motifs and the induced fit mechanism in class I ketol-acid reductoisomerases
    Cahn, Jackson K. B.
    Brinkmann-Chen, Sabine
    Spatzal, Thomas
    Wiig, Jared A.
    Buller, Andrew R.
    Einsle, Oliver
    Hu, Yilin
    Ribbe, Markus W.
    Arnold, Frances H.
    [J]. BIOCHEMICAL JOURNAL, 2015, 468 : 475 - 484